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A Novel Transcription Factor, T-bet,
Directs Th1 Lineage Commitment
that results in differentiation toward the Th1 or Th2 lin-
eage. Although this differentiation program can be influ-
enced by the antigen concentration or through ligation
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of costimulatory molecules, the most potent regulators*Department of Immunology and Infectious Diseases
of Th cell differentiation are undoubtedly cytokines (re-Harvard School of Public Health
viewed in Abbas et al., 1996; Constant and Bottomly,Boston, Massachusetts 02115
1997; O'Garra, 1998). The critical Th2-inducing cytokine²Department of Medicine
is IL-4, which mediates its effects on naive Thp cellsHarvard Medical School
through the Stat6 signaling pathway. Mice lacking eitherBoston, Massachusetts 02115
IL-4, IL-4 receptors, or Stat6 fail to develop Th2 cells³Department of Medicine
(reviewed in Nelms et al., 1999). IL-12, acting via theDivision of Rheumatology and Immunology
Stat4 signaling pathway, is the primary inducer of Th1Stanford University School of Medicine
development. Mice deficient in IL-12, IL-12 receptor b1,Stanford, California 94305
or Stat4 have markedly reduced Th1 responses (re-§Department of Medicine
viewed in Gately et al., 1998). While mice lacking IL-18 orDivision of Rheumatology and Immunology
IFNg have defective in vivo Th1 responses, these cytokinesMedical University of South Carolina
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Th1 and Th2 cytokines both promote the growth/dif-
ferentiation of their subset and inhibit the growth/differ-
Summary entiation of the opposing subset. For example, IL-4 pro-
duced by Th2 cells acts in a positive manner to activate
Naive T helper cells differentiate into two subsets, Th1 IL-4 receptors present on naive Thp cells to initiate the
and Th2, each with distinct functions and cytokine Th2 differentiation process (Seder and Paul, 1994). In
profiles. Here, we report the isolation of T-bet, a Th1- addition, IL-4 acts in a negative manner to extinguish
specific T box transcription factor that controls the IL-12 receptor expression on the developing cells, com-
expression of the hallmark Th1 cytokine, IFNg. T-bet mitting them to the Th2 lineage (Szabo et al., 1997;
expression correlates with IFNg expression in Th1 and Ouyang et al., 1998). Moreover, IL-10, a cytokine prefer-
NK cells. Ectopic expression of T-bet both transacti- entially expressed by Th2 cells, inhibits IL-12 production
vates the IFNg gene and induces endogenous IFNg by activated macrophages, thus indirectly inhibiting Th1
production. Remarkably, retroviral gene transduction development (Fiorentino et al., 1991). Th1-produced
of T-bet into polarized Th2 and Tc2 primary T cells IFNg promotes Th1 development by inducing IL-12 pro-
redirects them into Th1 and Tc1 cells, respectively, as duction from activated macrophages and IL-12 receptor
evidenced by the simultaneous induction of IFNg and expression on antigen-activated Thp cells (Ma et al.,
repression of IL-4 and IL-5. Thus, T-bet initiates Th1 1996; Szabo et al., 1997), while directly inhibiting the
lineage development from naive Thp cells both by acti- growth of Th2 cells (Gajewski et al., 1989). Thus, the
vating Th1 genetic programs and by repressing the cytokines produced by each Th subset form positive
opposing Th2 programs. and negative feedback loops that drive T helper cell
polarization. The dual activity of Th cytokines results
in the predominance of a particular Th phenotype asIntroduction
exemplified by the Th polarity seen in chronic infectious
diseases (Romagnani, 1994).T helper (Th) lymphocytes differentiate into two distinct
Significant progress has been made in identifying thesubsets, Th1 and Th2, as defined by functional abilities
transcription factors that control the transition of a Thpand cytokine profiles (Mosmann and Coffman, 1989;
to a Th2 cell. The Th2-specific transcription factor,Seder and Paul, 1994). Th1 cells mediate delayed type
c-Maf, along with NFAT and NIP45 (an NFAT interactinghypersensitivity responses and provide protection against
protein), confers on a non-T cell the ability to produceintracellular pathogens and viruses. Th2 cells provide
endogenous IL-4 (Hodge et al., 1996), and c-maf-defi-help to B cells and eradicate helminthes and other extra-
cient mice have severely impaired IL-4 production (Kimcellular parasites. The functional differences between
et al., 1999). GATA-3, like c-maf, is Th2 specific andTh subsets are explained primarily through the activities
upregulated during Th2 differentiation (Zhang et al.,of the cytokines they secrete. IFNg is the signature cyto-
1997; Zheng and Flavell, 1997). However, GATA-3 ap-kine of Th1 cells, which also produce IL-2 and TNFb
pears to regulate a broad spectrum of Th2 cytokine(LT). IL-4 is the corresponding signature cytokine of Th2
genes as evidenced by the ectopic expression ofcells, which also secrete IL-5, IL-6, IL-9, and IL-13.
GATA-3 or dominant-negative GATA-3 in transgenic and
Upon encountering antigen, the naive CD41 T helper
retroviral transduction studies (Zheng and Flavell, 1997;
precursor (Thp) cell enacts a specific genetic program
Ouyang et al., 1998; Ferber et al., 1999; Zhang et al.,
1999). Additionally, Stat6 was necessary for the chroma-
tin remodeling of the IL-4/IL-13 locus found to occur ink To whom correspondence should be addressed (e-mail: lglimche@
hsph.harvard.edu). developing Th2 cells (Agarwal and Rao, 1998). Thus,
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GATA-3 and Stat6 appear to have a more global influ- Restriction enzyme analyses and sequencing re-
ence on Th2 cytokine gene expression and may mediate vealed that all eight clones were related or identical.
this effect by directly altering the chromatin structure Sequence comparison of these clones with the NCBI
of Th2-specific gene loci. GenBank sequence database yielded homology with the
In contrast to Th2 differentiation, very little is known T box family of transcription factors (Figure 1A). We
about the molecular basis of Th1 differentiation. The named our novel gene T-bet, for T box expressed in
only known transcription factors whose absence results T-cells. T-bet is a 530±amino acid protein with a 189±
in a failure to generate Th1 cells are Stat4 (Kaplan et amino acid T box DNA-binding domain (underlined). The
al., 1996; Thierfelder et al., 1996) and IRF-1 (Lohoff et human T-bet ortholog was subsequently cloned and
al., 1997; Taki et al., 1997), neither of which is Th1 re- shares 88% amino acid identity to murine T-bet (data
stricted. The lack of Th1 cells in IRF-1-deficient mice is not shown). The T box family of transcription factors
likely due to its direct effect in controlling transcription is defined by homology among family members in a
of the IL-12 gene although IRF-1 was shown to be a 200±amino acid DNA-binding domain called the T box
Stat4 target gene in T cells (Coccia et al., 1999), and thus (reviewed in Papaioannou, 1997; Smith, 1997). The T-bet
a defect in the T cell compartment may also contribute to DNA-binding domain (residues 138±327) is most similar
this phenotype in vivo. The Ets family member ERM, to murine T brain and Xenopus eomesodermin and thus
which is induced by IL-12 in a Stat4-dependent manner, places T-bet in the Tbr1 subfamily of the T box gene
has recently been reported to be Th1 specific, but it family. These three proteins share 69% amino acid iden-
does not affect the production of Th1 cytokines (Ouyang tity in the T box region (Figure 1B). Outside of the T box
et al., 1999). domain, T-bet bears no significant sequence homology
To isolate transcription factors that account for tissue- to other T box family members or to any other known
specific expression of Th1 type cytokines, we used a gene.
yeast expression cloning strategy in combination with
RDA (representational difference analysis). This meth- T-bet Expression Is Restricted to the Th1 Subset
odology resulted in the isolation of a novel protein be- and Is Regulated by Signals Transmitted
longing to the T box family of transcription factors. Mem- via the T Cell Receptor
bers of this family, whose founding member is the T-bet was isolated from a Th1 cDNA library and hybrid-
brachyury gene, play critical roles in diverse develop- ized to a Th1-specific probe. To confirm the apparent
mental processes (Papaioannou, 1997; Smith, 1997). We Th1 restricted nature of T-bet, we examined T-bet ex-
have named our gene T-bet (T-box expressed in T cells) pression in T helper cell clones. Northern blot analysis
since it is expressed selectively in thymocytes and Th1 of RNA isolated from Th1 cell clones (PL17, OF6, and
cells. T-bet is a Th1-specific transcription factor that AE7) or Th2 clones (CDC35 and D10) revealed T-bet
plays a central role in Th1 development. T-bet transacti- transcripts only in the Th1 clones (Figure 2A). Further,
vates the IFNg gene, induces IFNg production in retrovi- T-bet expression was augmented by signals transmitted
rally transduced primary T cells, and redirects polarized via the TCR as evidenced by the induction of T-bet
Th2 cells into the Th1 pathway.
transcripts by anti-CD3 at 6 and 24 hr. T-bet transcripts
were not detected in untreated or PMA plus ionomycin±
Results
treated EL4, a thymoma, M12, a B cell lymphoma, or
Jurkat, a T cell lymphoma. To examine T-bet proteinCloning of a Novel T box Transcription
expression, we generated monoclonal (mAb) and poly-Factor, T-bet
clonal antisera specific to T-bet. Western blot analysisWe reasoned that Th1-specific transcription factors
revealed an approximately 62 kDa protein present inshould control the expression of the IL-2, IFNg, or TNFb
nuclear extracts prepared from resting and PMA/iono-genes. Several transcription factors are important for
mycin-activated (1 hr) AE7 cells but not activated D10IL-2 gene transcription, including NFAT, AP-1, NF-kB,
cells (Figure 2B, left). T-bet protein was also directlyHMG, and Oct proteins, but none of these accounts for
visualized by FACS analysis of permeabilized cells usingthe tissue-specific expression of IL-2 in Thp and Th1
the T-bet-specific mAb 4B10 (Figure 2B, right). T-betcells. However, since the Th1-specific region of the IL-2
protein was undetectable in D10 cells and present atpromoter had been well localized (Brombacher et al.,
low levels in unstimulated AE7 cells and at increased1994; Lederer et al., 1994), we chose a yeast one hybrid
levels in stimulated AE7. Taken together, these experi-approach using this region of the IL-2 promoter (-400
ments demonstrate that in T cell clones, T-bet is selec-to 240) linked to the HIS3 reporter gene. The EGY48
tively expressed in Th1 cells and its level of expressionyeast strain was stably integrated with the IL-2 pro-
is augmented by signals mediated through the TCR.moter/HIS3 construct and transformed with an activated
A multiple organ Northern blot revealed T-bet tran-Th1 cell library of cDNAs fused to the B42 activation
scripts only in lung, thymus, and spleen, a distributiondomain. Of 5.6 3 106 transformants, 488 grew on agar
suggestive of T cell restricted expression (Figure 3A). Toplates containing the selection media. Of the 210 clones
examine the kinetics of T-bet protein expression duringtested during the secondary screen, 72 were induced
primary stimulation of T cells, DO11.10 TCR transgenicby galactose, indicating promoter-induced specificity.
splenocytes were activated in the presence of Th1- orWe then utilized a screening procedure using Th1- and
Th2-inducing conditions and nuclear extracts preparedTh2-specific radiolabeled probes generated via RDA
on day 0, 2, 3, 4, 6, and 8 (Figure 3C). T-bet protein wasfrom mRNA from anti-CD3-activated Th1 (PL17) and Th2
not expressed in resting splenocytes but was rapidly(D10) clones. Of the 16 clones screened, 8 were positive
and selectively induced in Th1- but not Th2-driven cells.with the Th1- but not the Th2-specific probe (data not
shown). Since naive Thp cells were not purified, NK cells and
T-bet Controls IFNg Expression
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Figure 1. Cloning of a Novel Transcription Factor, T-bet
(A) Nucleotide and deduced amino acid sequence of murine T-bet. T-bet is a 530±amino acid protein with a 189±amino acid T box DNA-
binding domain (underlined).
(B) T-bet shares a region of homology with the T box family members T-brain and eomesodermin. Bold lettering indicates shared amino acid
identity.
memory T cells along with other cell types could be nuclear extracts from AE7 but not D10 cells that is super-
shifted by a T-bet mAb bind to a consensus T box sitecontributing to T-bet expression. Therefore, we FACS
purified naive DO11.10 cells and activated them with and to a T box site in the IL-2 promoter, and T-bet
transactivates a multimerized T box site in transientplate-bound anti-CD3 and anti-CD28 under Th1- or Th2-
polarizing conditions and isolated RNA on day 0, 1, 2, transfection assays (data not shown). These data sug-
gested that T-bet may activate IL-2 gene transcription.3, 5, and 8. In resting naive Thp cells, T-bet RNA was
undetectable (Figure 3B). However, in T cells cultured However, T-bet did not transactivate an IL-2 promoter/
reporter either alone or in combination with other tran-under Th1- but not Th2-inducing conditions, abundant
T-bet RNA expression was detected with maximal in- scription factors (NFAT, AP-1, and NF-kB) (data not
shown). Furthermore, Western blot analysis of nuclearduction noted 24 hr after stimulation. Thus, T-bet ex-
pression is rapidly induced in primary T cells developing extracts prepared from YT and NK3.3 (human NK), Jur-
kat, EL4, and M12 cells showed T-bet protein only in YTalong the Th1 but not the Th2 pathway.
cells (Figure 3D). It was puzzling that two IL-2-producing
cell lines, Jurkat and EL4, did not express T-bet, whileT-bet Expression Correlates with IFNg Induction
in NK and B Cells the NK cell line YT, which does not produce IL-2, did
express T-bet. One candidate gene that T-bet couldThe T box domain of Xbra (a Brachyury ortholog) has
been cocrystallized with DNA and demonstrates a novel potentially regulate, and which could explain its tissue
distribution, was the cytokine gene IFNg. Th1 and NKsequence-specific DNA recognition architecture in which
the protein contacts DNA in both the major and minor cells express IFNg, which is induced upon TCR activa-
tion or cytokine stimulation, respectively. Additionally,grooves (MuÈ ller and Herrmann, 1997). The nucleotides
critical for binding are present within the proximal IL-2 IFNg is not expressed by Th2 cells, M12, EL4, or Jurkat
cells.promoter. Recombinant T-bet protein and a protein in
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Figure 2. T-bet Expression Is Restricted to
Th1 Clones
(A) Expression of T-bet RNA in T helper cell
clones. Th1 cell clones (PL17, OF6, and AE7)
or Th2 clones (CDC35 and D10) treated with
media or with plate-bound anti-CD3 for 6 and
24 hr, EL4, M12, and Jurkat untreated or PMA
and ionomycin for 6 hr (PI).
(B, left panel) T-bet protein expression in Th
cell clones. Western blot analysis was per-
formed on nuclear extracts prepared from
resting or PMA/ionomycin-stimulated (1 hr)
bulk culture AE7 or D10 cells.
(B, right panel) Flow cytometric analysis of
T-bet expression. AE7 or D10 were treated
with media or PMA plus ionomycin for 5
hr, washed, fixed, and permeabilized, and
stained with media (dashed line), an IgG1 iso-
type control antibody (dotted line), or an affin-
ity-purified anti-T-bet mAb (4B10, solid line),
followed by goat anti-mouse IgG1-PE.
We first attempted to correlate the expression of T-bet expression and secretion of IFNg in NK3.3 cells that
produce IFNg only upon treatment with IL-2 and IL-12with IFNg expression in non-T cells. Primary B cells,
which do not produce IFNg at baseline, can be induced (data not shown). In conclusion, while neither cell type
expresses T-bet at baseline, both B cells and NK cellsto produce large amounts of IFNg upon treatment with
anti-CD40 antibody plus IL-12 and IL-18 (Yoshimoto et can be induced to express T-bet under conditions that
result in IFNg production. Thus, the pattern of T-betal., 1997). Purified B2201 splenic B cells were treated
for 72 hr with anti-CD40 mAb, rIL-12, and rIL-18, and expression correlates well with the production of IFNg.
RNA was isolated. Figure 3E shows induction of T-bet
RNA in B cells treated with this combination of reagents,
and the coordinate induction of IFNg, but not IL-2, as T-bet Is a Potent Transactivator of the IFNg Gene
The regions of the IFNg gene that direct its tissue-spe-measured by ELISA. During the B cell purification proce-
dure, contaminating NK cells may be present, and thus cific expression have not been identified either in vitro
or in vivo. Reporter constructs containing 500 bp or 3under these culture conditions NK cells could contribute
to the IFNg production (Rolink et al., 1996). However, kb of upstream sequence are expressed in both Th1
and Th2 cells (Young et al., 1994). ATF-2, NF-kB, AP-1,we have also observed the coordinate induction of T-bet
Figure 3. T-bet Is Expressed Early in Devel-
oping Th1 Cells and NK Cells
(A) Tissue distribution of T-bet. Northern anal-
ysis of an organ blot probed with the T-bet
or HPRT cDNA probe.
(B) Kinetics of induction of T-bet transcripts in
primary T cells. Naive Mel141 CD41 DO11.10
TCR transgenic T cells were activated under
Th1- or Th2-polarizing conditions and RNA
prepared on day 0, 1, 2, 3, 5, and 8 after
primary activation.
(C) T-bet expression in antigen-APC-acti-
vated primary T cells. DO11.10 TCR trans-
genic splenocytes were activated with OVA
peptide at 3 3 106 cells/ml in the presence
of Th1- or Th2-polarizing conditions and
Western blot analysis performed on 30 mg of
nuclear extracts prepared on day 0 ,2, 3, 4,
6, and 8 after primary activation and probed
with polyclonal anti-T-bet antisera.
(D) T-bet protein expression in cell lines.
Western blot analysis of YT, NK3.3, Jurkat,
EL4, and M12 cells.
(E) T-bet expression correlates with IFNg pro-
duction in B cells. B2201 splenic B cells puri-
fied by FACS and treated for 72 hr with vari-
ous combinations of anti-CD40 mAb, rIL-12,
and rIL-18 were subjected to Northern blot
analysis using T-bet and HPRT probes. IFNg
levels in culture supernatants were measured
by ELISA.
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YY1, NF-AT, and Stat sites in the IFNg promoter or in-
trons are functionally important but have not been
shown to be responsible for the tissue-specific expres-
sion of IFNg (Young et al., 1994; Penix et al., 1996; Xu
et al., 1996; Sica et al., 1997; Sweetser et al., 1998).
Additionally, although Th1-preferential DNaseI hyper-
sensitive sites have been noted both in the first and
third introns, the relevant cis elements have not been
identified (Young et al., 1994; Agarwal and Rao, 1998).
The T box transcription factors have a consensus bind-
ing site (Figure 4A). Inspection of the IFNg gene revealed
three potential T box binding sites, two located within
the proximal promoter region and one in the third intron.
We therefore tested whether T-bet could transactivate
a reporter construct containing the entire IFNg locus.
This reporter construct contains 9.2 kb of genomic DNA,
including the IFNg coding sequence with all three in-
trons, 3 kb of upstream sequence, and 1.5 kb of down-
stream sequence (Figure 4B). Cotransfection of the
mouse thymoma EL4, which produces IL-2 and IL-4 but
not IFNg, with a T-bet cDNA expression plasmid and
the IFNg-luciferase reporter construct resulted in sub-
stantial (20- to 40-fold) transactivation of the IFNg gene
evident both in unstimulated and PMA/ionomycin-stim-
ulated cells (Figure 4C). Further, EL4 cells were tran-
siently transfected with T-bet or empty vector and en-
dogenous IFNg production measured by ELISA at 24, 48,
and 72 hr after PMA/ionomycin stimulation. Remarkably,
ectopic expression of T-bet in EL4 cells led to substan-
tial IFNg production (Figure 4D). These results are a
novel demonstration of a Th1 restricted transcription
factor capable of transactivating the IFNg gene and in-
ducing endogenous IFNg production.
We then determined if ectopic expression of T-bet
affected the transcription of other cytokine genes. Sur-
Figure 4. T-bet Transactivates the IFNg Gene and Represses theprisingly, we found T-bet expression repressed the ac-
IL-2 Gene in EL4 Cellstivity of an IL-2 promoter/reporter construct an average
(A) Putative T box sites in the IL-2 and IFNg genes as compared toof 5- to 10-fold in PMA/ionomycin-stimulated EL4 cells
a consensus T box sequence.(Figure 4C). T-bet did not repress basal IL-2 promoter
(B) Schematic drawing of the 9.2 kb IFNg reporter construct.activity in unstimulated EL4 cells. Additionally, T-bet
(C) Analysis of IL-2, IL-4, and IFNg promoter transactivation in EL4
expression had no effect on IL-4 promoter transactiva- cells. The following plasmids were used: an IL-2 promoter/reporter
tion (Figure 4C) or a nonspecific control Egr-3 promoter construct (IL-2.luc, containing 22060 to 140 of the IL-2 promoter),
an IL-4 promoter/reporter construct (IL-4.luc, containing 2760 toconstruct (data not shown). Thus, T-bet is a potent trans-
168 of the IL-4 promoter), and the IFNg reporter construct describedactivator of the IFNg gene and can simultaneously re-
above (IFNg.luc). Striped bars are empty pCDNA vector, and solidpress IL-2 gene transcription in stimulated EL4 cells.
bars are the T-bet expression vector. Left panel is unstimulated
cells, and right panel is stimulation with PMA plus ionomycin for 5
Retroviral Gene Transduction of T-bet into Primary hr. The luciferase units in the bars marked with an asterisk represent
1/20 of actual activity. The data shown are representative of threeT Cells Results in Increased IFNg Production
independent experiments.The experiments described above argue strongly for a
(D) Endogenous IFNg production in EL4 cells transiently transfectedcritical role of T-bet in controlling IFNg transcription. To
with T-bet. The striped bars are pCDNA vector alone and the solidfurther test whether T-bet is responsible for the tissue-
bars are T-bet expression plasmid. PMA plus ionomycin was added
specific expression of IFNg, retroviral gene-mediated 12 hr after transfection and the level of IFNg produced at 24, 48,
transfer of T-bet into primary T cells was performed. and 72 hr measured by ELISA. The data shown are representative
of three independent experiments.We generated two different bicistronic retroviral vectors
expressing both T-bet and GFP (Figure 5A). The retrovi-
ral vectors containing GFP only (GFP-RV and pGC) were staining. Transduction of primary CD41 T cells with T-bet
used in all experiments to control for the effects of ret- resulted both in a dramatic increase in the number of
roviral infection. BALB/c CD41 T cells were activated cells producing IFNg (74% versus 4%) and in the amount
with anti-CD3 and anti-CD28 and infected with retrovirus of IFNg produced per cell as compared to cells trans-
36 hr after primary activation. After 7 days of culture, duced with GFP alone (Figure 5B). Interestingly, IL-2
GFP-positive cells were isolated by FACS, rested over- production remained unchanged. The effect of T-bet in
night in IL-2, and stimulated with PMA/ionomycin and Th differentiation was also assayed using an antigen-
specific TCR transgenic system. MBP TCR transgeniccytokine production was measured by intracellular
Cell
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Figure 5. Retroviral Gene Transduction of
T-bet into Primary CD41 T Cells Induces IFNg
Production
(A) Schematic diagram of retroviral con-
structs.
(B) Retroviral transduction of primary CD41
T cells with control GFP-RV and T-bet/GFP-
RV. FACS-purified BALB/c CD41 T cells were
infected with the indicated retroviral con-
struct 36 hr after primary activation by anti-
CD3 plus anti-CD28. Cells were harvested on
day 7, resorted for GFP expression, rested
overnight in IL-2, and intracellular cytokine
staining performed. Data are shown as two-
color dot plots showing GFP (horizontal axis)
versus intracellular cytokine (vertical axis) ex-
pression.
(C) Transduction of MBP TCR transgenic T
cells. Splenocytes were stimulated with 6 mM
MBP and infected after 24 hr with GFP alone
(pGC) or T-bet/GFP (T-bet/pGC). On day 7,
cells were sorted for CD4 and GFP expres-
sion, rested overnight in IL-2, and intracellular
cytokine analysis was performed. Data are
shown as two-color dot plots showing a first
intracellular cytokine staining (vertical axis)
versus a second intracellular cytokine (hori-
zontal axis) of events gated on GFP ex-
pression.
splenocytes were activated with MBP peptide for 24 hr GFP (89% to 75%). Thus, in primary T cell cultures T-bet
expression is a potent inducer of IFNg production.and the cells infected with GFP alone (pGC) or T-bet/
GFP (T-bet/pGC). On day 7, cells positive for CD4 and
GFP were isolated by FACS and rested overnight in T-bet Activates IFNg and Represses IL-4 Production
IL-2, and cytokine production was measured. Similar to in Developing Th2 Cells
the transduced polyclonally activated BALB/c T cells, a We next asked whether T-bet could induce IFNg produc-
marked increase was seen in IFNg by MBP-TCR trans- tion in Thp cells activated in the presence of stimuli that
genic T cells transduced with T-bet/GFP (90%) com- would drive them toward the Th2 lineage. CD41 T cells
pared to cells transduced with GFP alone (35%) (Figure were activated under Th2-inducing conditions, retroviral
5C). Additionally, a modest repression in IL-2 production infection was performed at 36 hr, and cells were ex-
panded with IL-2. The Th2 culture conditions were main-was noted in the transgenic T cells transduced with T-bet/
T-bet Controls IFNg Expression
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Figure 6. T-bet Activates IFNg and Represses
IL-4 Production in Developing Th2 Cells by
Invoking a Th1 Developmental Program
FACS-purified BALB/c CD41 T cells were ac-
tivated with anti-CD3 and anti-CD28 in the
presence of Th2-inducing conditions, retrovi-
ral infection with either GFP alone (GRP RV)
or T-bet (T-bet/GFP RV) was performed at 36
hr, and cells were expanded with IL-2 and
maintained under Th2-polarizing conditions.
On day 7, GFP-positive cells were sorted and
rested overnight in IL-2.
(A) Intracellular cytokine staining analysis
was performed after stimulation with PMA/
ionomycin for 2 hr and an additional 2 hr incu-
bation with 3 mM monensin.
(B) Surface expression of PSGL-1 was ana-
lyzed by FACS after 5 hr of stimulation with
PMA/ionomycin.
tained at each step throughout the 7 day experiment. shown). We conclude that T-bet can overcome Th2-
On day 7, GFP-positive cells were sorted and rested promoting signals to induce Th1 differentiation as evi-
overnight in IL-2, and cytokine production was mea- denced by the increased expression of IFNg, PSGL-1,
sured. Transduction with control GFP-RV alone resulted in and CCR5.
a population that contained 1% IFNg producers and 16%
IL-4-producing cells (Figure 6A). Introduction of T-bet/
GFP RV not only induced IFNg production but also T-bet Redirects Effector Th2 Cells
into the Th1 Pathwayinduced a substantial shift in the Th2 developmental
program of these Thp cells toward the Th1 phenotype A naive Thp has the potential to differentiate along the
Th1 or Th2 pathway. This developmental window re-as evidenced by the large number of IFNg-producing
cells (53%) and the reduced number of IL-4-producing mains open during the first 48 hr of primary T cell activa-
tion (Nakamura et al., 1997). However, after 7 days ofcells (4%). Remarkably, the redirection of the Th2 ge-
netic program occurred in the continuous presence of differentiation Th cells are referred to as effector cells,
since the developmental program is complete and exog-conditions that inhibit Th1 differentiation.
To further address whether T-bet was inducing a Th1 enous signals are not required to maintain the cell in its
differentiated state (Huang et al., 1997). To determine ifdevelopmental program in these differentiating Th2
cells, we analyzed the expression of Th1-specific genes T-bet could redirect the commitment of effector Th2
cells, CD41 T cells were polyclonally activated and cul-other than IFNg. Several surface markers that distin-
guish fully differentiated effector Th1 and Th2 cells have tured under Th2-polarizing conditions, and retroviral
gene transduction was performed at day 9 rather thanbeen recently identified. Th1 preferentially expressed
genes include the IL-12 receptor b2 chain, IL-18 recep- day 2 of culture. In these effector Th2 cells, control GFP-
transduced cells were IL-4 and IL-5 producers (77% andtor, CCR5, and CXCR3 chemokine receptors, and a
modified form of P-selectin glycoprotein-1 (PSGL-1) that 59%) with barely detectable IFNg producer cells present
(,1%) (Figure 7A). Remarkably, introduction of T-betcan be detected using the P-selectin-Ig reagent (Borges
et al., 1997). Thp cells under Th2-polarizing conditions into effector Th2 cells redirected them into Th1 cells as
evidenced both by the induction of IFNg expression andwere retrovirally transduced as above. On day 8, GFP-
positive cells were stimulated with PMA/ionomycin for the loss of IL-4 and IL-5 expression. Fully 83% of T-bet-
transduced Th2 cells now produced IFNg while the5 hr, and surface expression of PSGL-1 and CCR5 were
analyzed. T-bet/GFP caused a modest increase in the percentage of cells producing IL-4 and IL-5 was reduced
to 26% and 4%, respectively. Additionally, there was amodified form of PSGL-1 (65%) expression compared
to control GFP infected cells (40%) (Figure 7B). This dramatic reduction in the amount and number of IL-2-
producing cells from 41% to 5%. These T-bet-trans-relative difference was similar to the differences in
PSGL-1 expression in nontransduced primary T cells duced cells are therefore not Th0 cells that produce
IL-2, IFNg, and IL-4. We conclude that T-bet has notdifferentiated along a Th1 (50%) versus Th2 (29%) path-
way in vitro (Figure 6B). Additionally, the expression simply induced IFNg expression in Th2 cells but appears
to be reprogramming Th2 cells into the opposing Th1of CCR5 in T-bet/GFP-transduced cells was similar to
levels expressed on nontransduced Th1 cells (data not subset.
Cell
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Figure 7. T-bet Converts Effector Th2 into Th1 Cells Independently of IFNg and Redirects Tc2 Cells into the Tc1 Pathway
FACS-purified wild-type 129 CD41, IFNgR2/2 CD41, or BALB/c CD81 T cells were activated with anti-CD3/CD28 in the presence of rIL-4, anti-
IFNg, and IL-12 mAbs to promote Th2 or Tc2 differentiation. Retroviral infection with either GRP RV or T-bet/GFP RV was performed on day
9 of culture, and cells were expanded with IL-2 and maintained under Th2/Tc2 culture conditions. On day 14, GFP-positive cells were sorted
and analyzed on day 15 by intracellular cytokine analysis. (A) Effector Th2 cells, (B) effector IFNgR2/2 Th2 cells, or (C) effector Tc2 cells.
T-bet Represses IL-4 and IL-5 Production in Th2 duced by T-bet-transduced Th2 cells inhibits IL-4 pro-
duction. To address this issue, we examined T-bet'sCells through an IFNg-Independent Pathway
T-bet clearly induces endogenous IFNg production in a ability to repress IL-4 production in Th2 cells that were
insensitive to IFNg signaling due to genetic deficiencynumber of different cell types and represses IL-4 pro-
duction in developing and effector Th2 cells. However, of the IFNg receptor (IFNgR2/2) (Huang et al., 1993).
IFNgR2/2 CD41 T cells were activated under Th2-polariz-T-bet did not repress IL-4 promoter transactivation in
EL4 cells. One explanation could be that the IFNg pro- ing conditions, and retroviral transduction was per-
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formed on day 9. Intracellular cytokine analysis showed To test whether T-bet could reverse the Th2 differentia-
Th2 development in the IFNgR2/2 CD41 T cells occurred tion program in a population of stably committed Th2
similarly to the control wild-type cells as evidenced by cells, CD41 DO11.10 T cells were stimulated under Th2-
the similar number of IL-4 and IL-5 producers (82% polarizing conditions for 22 days (Figure 8B), and retrovi-
and 81%) and the presence of few IFNg-producing cells ral transduction was then performed. The histograms in
(,1%). When T-bet was introduced into these IFNgR2/2 Figure 8B indicate the retroviral transduction efficien-
Th2 cells, a dramatic reduction in IL-4 and IL-5 expres- cies between the GFP RV (46%) and T-bet GFP RV (86%)
sion (21% and 5%, respectively), a marked increase in populations. On day 28, intracellular cytokine staining
the number of IFNg-producing cells (73%), and a de- was performed on the unfractionated populations. Indi-
crease in the number of IL-2-producing cells (43% to cated in the upper left panel of each FACS plot is the
8%) was observed. Thus, T-bet's ability to repress IL-4 percent cytokine-positive cells of the nontransduced
and IL-5 is not an indirect effect of IFNg overproduction cell population (GFP2), while the percent cytokine-posi-
on the T cells. tive cells of the retrovirally transduced cell population
(GFP1) is indicated in the upper right panel. In the GFP1
T-bet Redirects Effector Tc2 Cells populations, provision of T-bet/GFP to stably committed
into the Tc1 Pathway Th2 cells converts them into Th1 cells as evidenced by
Cytotoxic CD81 T cells may also be divided into IFNg- the increased number of cells producing IFNg (2% to
producing (Tc1) and IL-4-producing (Tc2) subsets (Croft 35%) and by the reduced number of T-bet/GFP-trans-
et al., 1994). We therefore asked whether introduction duced cells producing IL-4 (88% to 44%) and IL-5 (71%
of T-bet into effector Tc2 cells could redirect them to to 6%). Comparison with the control GFP2 population
the Tc1 phenotype. Purified BALB/c CD81 T cells were shows that the cytokine profiles of the nontransduced
activated with anti-CD3/CD28 in the presence of Tc2- populations are nearly identical in the GFP RV and T-bet/
polarizing conditions, and retroviral infection was per- GFP RV-treated cultures, with respect to IL-4 (87%
formed on day 9. Figure 7C demonstrates that T-bet versus 82%), IL-5 (67% versus 65%), and IFNg (1% ver-
transduction into Tc2 cells induced a striking increase sus 5%). Thus, T-bet's ability to repress IL-4 and IL-5 is
in IFNg-producing cells (14% versus 86%) and dramati- not due to soluble factors but is due to T-bet expression
cally repressed the production of IL-2 (16% versus 2%), within the cell.
IL-4 (34% versus 4%), and IL-5 (45% versus 2%). We
conclude that T-bet expression is able to convert differ- T-bet Represses IL-4 and IL-5 Production
entiated CD81 Tc2 cells to Tc1 cells. in Th2 Clones
Lastly, T-bet's ability to repress IL-4 and IL-5 production
T-bet Converts Polarized Th2 Cells into Th1 Cells was assayed in a homogeneous population of Th2 cells.
Relatively little is known about the biological mecha- For these experiments, the D10 Th2 clone (Figure 8C)
nisms through which T box transcription factors exert and two additional Th2 clones, HAE4A6 and 1A8, were
their functions. It is possible that T-bet may be involved used (data not shown). D10 cells were stimulated and
in cell cycle control and could give a selective growth retroviral infection performed on day 1, and cells were
advantage to infected cells. It was also possible that expanded with IL-2. On day 7, GFP-positive cells were
retroviral infection was occurring in a small population enriched, restimulated, and expanded, and were ana-
of uncommitted Thp cells that then predominated over lyzed on day 14 by intracellular cytokine analysis. Ret-
the course of the experiment. To address these possibili- roviral transduction efficiency is shown as a histogram,
ties, naive CD41 DO11.10 T cells were activated under
and the FACS plots reflect events gated on GFP1 ex-
Th2-polarizing conditions for 15 days, and retroviral
pression. In D10 cells, T-bet inhibited the Th2 genetic
transduction was performed. On day 21, GFP1 and GFP2
program as evidenced by the reduced number of T-bet/cells were sorted from both the GFP RV and T-bet/
GFP-transduced cells producing IL-4 (54% to 12%) andGFP RV-transduced cultures, and proliferation assays
IL-5 (70% to 14%). In this cell line, T-bet minimally in-demonstrated that the growth rates between all popula-
duced IFNg production (1% to 7%). Similar results weretions were similar (data not shown). Intracellular cyto-
obtained with the two additional Th2 clones, HAE4A6kine staining of the GFP1 populations demonstrates that
and 1A8 (data not shown). These results demonstrateprovision of T-bet/GFP to polarized Th2 cells converts
that T-bet's ability to suppress Th2 development ex-them into Th1 cells as evidenced by the increased num-
tends even to long-term, established Th2 clones.ber of cells producing IFNg (,1% to 71%) and TNFa,
another cytokine preferentially produced by Th1 cells
Discussion(26% to 46%). The effect of T-bet not only initiated a
Th1 program but also inhibited the Th2 program as evi-
CD41 T helper cells have been classified into two sub-denced by the reduced number of T-bet/GFP-trans-
sets based on their distinct patterns of cytokine secre-duced cells producing IL-4 (68% to 42%) and IL-5 (48%
tion. The hallmark cytokine produced by the Th1 subsetto 2%).
is IFNg, and the corresponding cytokine of the Th2 sub-
set is IL-4. In contrast to the substantial progress thatT-bet Converts Fully Polarized Th2 Cells into Th1
has been made in identifying the factors that direct Th2-Cells by a Mechanism Directly Dependent
specific IL-4 expression, no information is available onon T-bet Expression
the corresponding Th1-specific factors that control IFNgReversibility of Th1 and Th2 populations is largely abro-
expression. Here, we provide strong evidence that thegated after 1 week in culture. However, stable commit-
selective expression of T-bet, a novel T box family mem-ment to a Th phenotype occurs after 3 weeks of stimula-
tion under Th-polarizing conditions (Murphy et al., 1996). ber, accounts for the Th1-specific expression of IFNg.
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Figure 8. T-bet Converts Fully Polarized Th2 Cells into Th1 Cells and Represses IL-4 and IL-5 Production in Th2 Clones
(A and B) FACS-purified naive DO11.10 TCR transgenic CD41 T cells were activated with 0.3 mM OVA peptide and irradiated BALB/c splenocytes
in the presence of Th2-inducing conditions. Retroviral infection was performed on day 15 or day 22 of culture, and cells were expanded with
IL-2 and maintained under Th2 culture conditions until day 21 or 28.
(A) On day 21, GFP-positive cells were sorted, and they were analyzed on day 22 by intracellular cytokine analysis.
(B) On day 28, retroviral transduction efficiency was determined by FACS and plotted as a histogram. Nontransduced (GFP2) and retrovirally
transduced (GFP1) cells were analyzed by intracellular cytokine analysis. The percent cytokine-positive cells of the total nontransduced cell
population (GFP2) is indicated in the upper left panel of each FACS plot and the percent cytokine-positive cells of the total retrovirally
transduced cell population (GFP1) is indicated in the upper right panel.
(C) D10 Th2 clone was activated with 0.1 mg/ml conalbumin presented by irradiated AKR splenocytes. Retroviral infection was performed on
day 1 of culture, and cells were expanded with IL-2. On day 7, GFP-positive cells were enriched, restimulated, expanded, and analyzed on
day 14 by intracellular cytokine analysis. Retroviral transduction efficiency was determined by FACS and plotted as a histogram. The FACS
plots reflect events gated on GFP1 expression.
T-bet is expressed only in Th1 and not in Th2 cells and with IFNg expression in Th1 cells, NK cells, and B cells,
and T-bet is a potent transactivator of the IFNg gene.is induced in the former upon transmission of signals
through the TCR. The expression of T-bet correlates Most convincingly, retroviral-mediated transduction of
T-bet Controls IFNg Expression
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T-bet into either Thp, Th2, or Tc2 cells results in a marked cells present in Th2 cultures. This discrepancy may re-
induction of IFNg expression. What is most exciting is flect the increased sensitivity of the intracellular cytokine
that the function of T-bet appears to extend beyond the assay for IL-2. Thus, we believe that Th2 cells produce
simple control of IFNg gene transcription. Thus, T-bet IL-2 albeit at lower levels then Th1 cells; however, we
converts both effector Th2 cells and effector Tc2 cells cannot rule out that there also exists a population of IL-
into the opposing Th1 and Tc1 subsets, respectively. 2-producing uncommitted cells within our Th2 cultures.
Moreover, T-bet can reprogram a stably committed pop- Regardless, the repression of IL-2 by T-bet as seen in
ulation of fully polarized Th2 cells into the Th1 phenotype this study is consistent with a function for T-bet in driving
and can even repress IL-4 and IL-5 production in Th2 lineage commitment from a naive precursor cell into a
clones. Taken together, these data lead us to conclude fully polarized Th1 effector cell. In contrast to the striking
that T-bet is responsible for the genetic program that results obtained using Th2 and Tc2 cells, only modest
initiates Th1 lineage development from naive Thp cells reduction of IL-2-producing cells was observed in devel-
and acts both by initiating Th1 genetic programs and oping Thp cells transduced with T-bet. These results
by repressing the opposing Th2 programs. may be explained by the presence of a developmentally
From this study, T-bet clearly regulates IFNg produc- regulated corepressor (Fisher and Caudy, 1998), or T-bet
tion in a number of cell types: EL4, primary T cells, may synergize with ZEB, a negative regulator of IL-2
developing Th2 cells, effector Th2 and Tc2 cells, and transcription, which binds the NRE site of the IL-2 pro-
fully polarized Th2 cells. However, in Th2 clones, while moter and is constitutively expressed in Th2 clones (Yasui
T-bet was capable of repressing IL-4 and IL-5 produc- et al., 1998).
tion it was unable to induce substantial IFNg production. How does T-bet repress the Th2 program in Thp and
It may be that there is a point in the life span of a Th2 Th2 cells? It is unlikely that it is a direct effect since T-bet
cell where T-bet is incapable of inducing IFNg secretion did not repress IL-4 promoter transactivation. Since the
because the chromatin configuration at the relevant loci observed repression also occurred in the absence of
is no longer accessible or because the array of factors IFNg receptor signaling, it cannot be explained by IFNg
necessary for IFNg gene expression is no longer present. acting directly on the T cell. An intriguing possibility is
Much remains to be learned about the exact mechanism that T-bet directly inhibits the activity of the GATA-3
by which T-bet regulates IFNg production. For instance, gene. The very pronounced effect of T-bet on IL-5, a
although we have found regions in the IFNg gene that cytokine gene directly regulated by GATA-3, is consis-
resemble T box binding sites, we have not yet deter- tent with this explanation. In this scenario, the somewhat
mined that T-bet binds to these sites. A thorough dissec- lesser effect of T-bet on inhibition of IL-4 gene expres-
tion of all of the upstream, downstream, and intronic sion could be explained by the predominant role of
regions of the IFNg gene will be necessary to address c-maf in controlling this gene. The effect of T-bet in
this issue. repressing the Th2 program while simultaneously en-
How does T-bet simultaneously transactivate the IFNg hancing the Th1 program is reminiscent of GATA-3,
gene and repress IL-2 transcription? The consensus T which indirectly represses IFNg expression through in-
box binding site was defined by target site selection in fluencing expression of the IL-12 receptor b2 chain while
vitro. Inspection of the murine IL-2 promoter reveals an simultaneously inducing Th2 differentiation (Ouyang et
excellent T box site at 2240 to 2220. Presumably, the al., 1998). Perhaps GATA-3 suppresses T-bet expres-
binding of T-bet to the IL-2 promoter explains its isola- sion during Th2 development. Thus, the predominance
tion in our yeast one hybrid screen where the readout of T-bet or GATA-3 may ultimately determine the fate
depended simply on binding of T-bet to drive a reporter of a developing Th cell toward the Th1 or Th2 lineage,
gene. Additionally, we have found three T box sites in respectively.
the IFNg gene locus, two sites at positions 22300 to It will be of interest to understand the basis for the
22291 and 21957 to 21948 and one in the third intron
tissue-specific expression of T-bet itself since our pre-
at position 14655 to 14665. While these T box sites
liminary data demonstrate that T-bet is regulated not
in the IFNg and IL-2 genes appear similar in transient
only by signals stemming from the TCR but also bytransfection assays, T-bet induced IFNg promoter activ-
signal transduction pathways downstream of the IL-12ity and repressed IL-2 promoter activity. An attractive
receptor. Thus, IL-12 induces an increase in levels ofmodel for a transcription factor acting as a context-
T-bet RNA and protein, and T cells derived from micespecific repressor or activator is the Drosophila tran-
lacking Stat4 have decreased expression of T-betscription factor dorsal. Dorsal typically acts as a tran-
(S. J. S., unpublished data). These data fit nicely withscriptional activator, yet it becomes a context-specific
the role of IL-12 and Stat4 in driving the developmentrepressor when dorsal binding sites are adjacent to VRE
of the Th1 lineage (Gately et al., 1998). While a criticalsites that bind the HMG1/2 protein DSP1 (Ip, 1995).
role for IL-12/Stat4 in driving the differentiation of naiveWe do not yet understand why repression of IL-2 ap-
Thp cells has been established, evidence has emergedpears strongest in effector Th2 cells. Naive Thp cells,
that effector Th1 cells can produce IFNg through TCRearly after stimulation, produce large amounts of IL-2,
stimulation only. While IL-12 may augment IFNg produc-which is then gradually replaced in polarized Th cells
tion in these cells, it is clearly not required. This is espe-by the effector cytokines IFNg and IL-4 (Seder and Paul,
cially true for CD81 cells where a Stat4-independent1994). As Th1 cells continue to polarize toward the ma-
pathway for IFN-g production has been demonstratedture Th1 phenotype, IL-2 expression is progressively
(Carter and Murphy, 1999). Analysis of T-bet gene tran-turned off. In contrast, Th2 cells are thought to turn off
scription itself in different cell types should prove infor-IL-2 production after the first week of differentiation. We
find, however, substantial numbers of IL-2-producing mative.
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sodium pyruvate (1 mM), and b-ME (50 mM). Jurkat is a human TBrachyury is the founding member of a family of tran-
cell lymphoma; EL4 a mouse thymoma; M12 a B cell lymphoma;scription factors that share a 200±amino acid DNA-bind-
NK3.3 a human NK cell line obtained from H. Young and J. Kornbluthing domain designated the T box (Papaioannou, 1997;
(Kornbluth et al., 1982); YT a human NK cell line obtained from Dr.
Smith, 1997). The isolation of the Brachyury gene (Herr- J. Yodoi (Yodoi et al., 1985); PL17 a mouse Th1 clone obtained from
mann et al., 1990) led to the identification of a family of Dr. P. Allen; AE7 and D1.1 mouse Th1 clones; and D10 and CDC35
mouse Th2 clones. All Th1 and Th2 clones were passaged as de-related genes in various species. Each T box gene has
scribed by Ho et al. (1996). Recombinant IL-4 was the gift of R.a distinct and developmentally regulated pattern of ex-
Coffman and A. O'Garra (DNAX), human rIL-2 the gift of Chironpression. Throughout evolution, T box family genes have
Corporation, rIL-12 the gift of Dr. M. Gately (Hoffman LaRoche), andbeen conserved in sequence and expression pattern in
rIL-18 purchased from Peprotech. Monoclonal anti-IL-12, monoclonal
species including Xenopus, zebrafish, chick, and hu- anti-IFNg (R4/GA2), monoclonal anti-IL-4 (11B11), and P-selectin-Ig
mans, as well as more distant species such as amphi- were purchased from Pharmingen. The CCR5 rabbit polyclonal anti-
body was the gift of P. Ponath (Leukocyte). Both the T-bet polyclonaloxus, ascidians, echinoderms, Caenorhabditis elegans,
antisera, produced in rabbits, and mAbs were raised against full-and Drosophila (Papaioannou, 1997; Smith, 1997). The
length recombinant bacterially produced T-bet protein. The 4B10essential role of T box family members in developmental
mAb was produced by fusion of mouse spleen cells to the SP2/O-processes has been exemplified in several systems. The
Ag14 myeloma and is of the IgG1 subtype.
Brachyury mutation was first described in heterozygous
mutant animals with a short tail. Homozygote mice were
Th1 cDNA Library Construction and Transformationmore severely affected as evidenced by defective meso-
Total RNA was purified from the Th1 clone OF6 (gift of S. Smiley)
derm formation, regression of the notochord, and em- activated with anti-CD3 and anti-CD28 for 3 and 6 hr. Poly A1 RNA
bryonic death from failure of the allantois to connect with was isolated on oligo dT magnetic beads (Dynal), double stranded
the placenta (Papaioannou, 1997; Smith, 1997). Recent cDNA synthesized by SuperScript Choices System (Gibco/BRL),
EcoRI adaptors ligated, cDNA fragments size fractionated on astudies determined that ectopic expression of Tbx4 in
sizesep400 spun column (Pharmacia), and cloned in the EcoRI sitechick limbs repatterns limb identity from forelimb to
of pJG4±5. The ligated product was transformed into DH5a (Gibco/hindlimb (Rodriguez-Esteban et al., 1999; Takeuchi et
BRL).
al., 1999). Mutations in the human T box genes TBX5 The murine IL-2 promoter (2400 to 240) was PCR amplified and
and TBX3 are responsible for the autosomal dominant cloned into the XbaI/SacI sites of pHISi-1 (Clontech), linearized with
genetic diseases Holt-Oram syndrome and ulnar-mam- XhoI, and stably integrated into the EGY48 yeast genome (pIL2/HIS/
EGY48). The OF6 Th1 cDNA library was transformed into pIL2/HIS/mary syndrome, respectively (Bamshad et al., 1997;
EGY48 using the Yeastmaker yeast transformation system kit follow-Basson et al., 1997). Both syndromes are characterized
ing the manufacturer's instructions (Clontech). The transformedby developmental defects reflected by the pattern of
yeast were grown in yeast media containing 2% glucose, 26.7 g/L
Tbx5 and Tbx3 expression. Holt-Oram syndrome affects DOB (drop out base) (Bio101), 0.72 g/L CSM (complete supplement
the heart and upper limbs while ulnar-mammary syn- mixture) -HIS -TRP, (Bio101) for 2 hr at 308C, washed twice in dH20,
drome affects limb, apocrine gland, tooth, and genital and grown for 16 hr in yeast medium containing 2% galactose, 2%
raffinose, 26.7 g/L DOB, and 0.72 g/L CSM -HIS -TRP, and thendevelopment. The mutations in these patients usually
plated onto agar plates containing the same media supplementedinvolve a point mutation in one allele of the T box gene,
with 145 mM aminotriazole (Sigma).and thus it has been postulated that haploinsufficiency
of Tbx5 and Tbx3 causes these two diseases. These
Cell Purification and In Vitro Culturesdiscoveries emphasize the critical importance of this
Naive CD41 T cells, CD41 T cells, CD81 T cells, and B2201 B cellsfamily in vertebrate development.
were purified by FACS (Mo Flo, Becton Dickenson) using anti-Mel14The recent prominence of the T box gene family arises
(CD62L), CD4, CD8, or B220 (Pharmingen) to 98%±99% purity. For
from its clear importance in diverse developmental pro- in vitro activation, 2 3 106/ml T cells were resuspended in CM and
cesses as exemplified most dramatically by the T box activated with plate-bound 2 mg/ml anti-CD3 (2C11) and 2 mg/ml
mutations in human disease. The generation of mature anti-CD28 (Pharmingen) for 3 days. For in vitro activation of DO11.10
TCR T cells, 0.5 3 106/ml were stimulated with 0.3 mM OVA peptideT cells from stem cells and the differentiation of Th cells
(323±339) with irradiated BALB/c splenocytes (10 3 106/ml, 2000from naive Th precursors can also be viewed as tightly
rads) for 3 days. Both types of cultures were then split 1:4 in CMregulated developmental processes. Our discovery that
with 200 U/ml IL2 and cultured for 4 days. In Figures 3 and 5,
T-bet is responsible for the development of the Th1 DO11.10 or MBP TCR transgenic spleen cells were fractionated on
lineage demonstrates an important role for this newest T histopaque gradients, washed, and resuspended at 3 3 106 cells/
box family member in the lymphoid system. A systematic ml with 0.3 mM OVA or with 6 mM MBP peptide (Ac1±11), respec-
tively. Cells were split 1:4 on day 3 with CM with 200 U/ml IL-2. Tostructure-function analysis, coupled with approaches to
induce Th1 and Th2 differentiation as indicated, the above culturesdetermine T-bet function in vivo, should provide further
included 5 ng/ml rIL-12 and 10 mg/ml anti-IL4 for Th1 cell develop-insight into molecular mechanisms that direct lineage
ment or 10 ng/ml rIL4, 10 mg/ml anti-IFNg, and 10 mg/ml anti-IL-12commitment in the immune system.
for Th2 cell development. For secondary and tertiary Th2 cultures,
cells were harvested on day 7 and day 14 after primary stimulation,
Experimental Procedures washed, and restimulated at 1 3 106 cells/ml with 2 mg/ml plate-
bound anti-CD3 and 2 mg/ml anti-CD28 in Th2-inducing culture con-
Mice, Cell Lines, Cytokines, Antibodies, and Plasmids ditions as indicated above.
BALB/c mice were obtained from Jackson Laboratories and
DO11.10 TCR-transgenic mice from K. Murphy (Hsieh et al., 1993),
Northern and Western Blot AnalysisMBP TCR-transgenic mice from C. Janeway (Lafaille et al., 1994),
Total RNA was isolated using TRIZOL reagent (Gibco/BRL), and 10and IFNgR2/2 mice from R. Schreiber (Huang et al., 1993). Cell lines
mg of each sample was separated on 1.2% agarose 6% formalde-and primary cells were maintained in complete medium (CM) con-
hyde gels, transferred onto GeneScreen membrane (NEN) in 203taining RPMI 1640 supplemented with 10% fetal calf serum (HyClone
SSC overnight, and covalently bound using a UV Stratalinker (Stra-Laboratories), glutamine (2 mM), penicillin (50 units/ml), streptomy-
cin (50 mg/ml), Hepes (100 mM), nonessential amino acids (13), tagene). Northern blots were hybridized using radiolabeled T-bet,
T-bet Controls IFNg Expression
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HPRT, or GAPDH cDNA probes. Whole cell extracts or nuclear ex- Bamshad, M., Lin, R.C., Law, D.J., Watkins, W.C., Krakowiak, P.A.,
Moore, M.E., Franceschini, P., Lala, R., Holmes, L.B., Gebuhr, T.C.,tracts were prepared as described (Szabo et al., 1995; Gouilleux et
al., 1994; respectively). Extracts (30 mg) were separated by 10% et al. (1997). Mutations in human TBX3 alter limb, apocrine and
genital development in ulnar-mammary syndrome. Nat. Genet. 16,PAGE followed by electrotransfer to nitrocellulose membranes and
probed with polyclonal antisera specific for T-bet followed by horse- 311±315.
radish peroxidase-conjugated goat anti-rabbit IgG and enhanced Basson, C.T., Bachinsky, D.R., Lin, R.C., Levi, T., Elkins, J.A., Soults,
chemiluminescence according to the manufacturer's instructions J., Grayzel, D., Kroumpouzou, E., Traill, T.A., Leblanc-Straceski, J.,
(Amersham). et al. (1997). Mutations in human cause limb and cardiac malforma-
tion in Holt-Oram syndrome. Nat. Genet. 15, 30±35.
Transient Transfection Assays Borges, E., Tietz, W., Steegmaier, M., Moll, T., Hallmann, R., Ha-
EL4 cells were transfected using a Bio Rad electroporator (280V, mann, A., and Vestweber, D. (1997). P-selectin glycoprotein ligand-1
975 mF) using 5 3 106 cells in 0.4 ml RPMI supplemented with (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin
20% FCS per transfection with 10 mg reporter plasmid and 10 mg and supports migration into inflamed skin. J. Exp. Med. 185,
expression plasmid. Luciferase assays were performed as de- 573±578.
scribed (Szabo et al., 1993). The IFNg reporter-luciferase construct
Brombacher, F., SchaÈ fer, T., Weissenstein, U., Tschopp, C., Ander-(IFNg.luc) was the gift of T. Hoey and is derived from the plasmid
sen, E., BuÈ rki, K., and Baumann, G. (1994). IL-2 promoter-drivenpB9, which contains the entire human (Gray and Goeddel, 1982).
lacZ expression as a monitoring tool for IL-2 expression in primaryThe pGL2 luciferase gene was inserted into the first exon of the
T cells of transgenic mice. Int. Immunol. 6, 189±197.IFNg gene. The luciferase reporter constructs (IL-2.luc and IL-4.luc)
Carter, L.L., and Murphy, K.M. (1999). Lineage-specific requirementwere the gift of K. Murphy (Szabo et al., 1993).
for signal transducer and activator of transcription (Stat)4 in inter-
feron g production from CD41 versus CD81 T cells. J. Exp. Med.Retroviral Constructs and Transduction
189, 1355±1360.The GFP-RV bicistronic vector was obtained from K. Murphy
(Ouyang et al., 1998) and the Phoenix-Eco packaging cell line from Coccia, E.M., Passini, N., Battistini, A., Pini, C., Sinigaglia, F., and
G. Nolan (Hofmann et al., 1996). The GFP-RV vector was constructed Rogge, L. (1999). Interleukin-12 induces expression of interferon
by inserting the encephalomyocarditis virus internal ribosomal entry regulatory factor-1 via signal transducer and activator of transcrip-
sequence (IRES) and the GFP allele into the MSCV2.2 retroviral tion-4 in human T helper type 1 cells. J. Biol. Chem. 274, 6698±6703.
vector as described (Ouyang et al., 1998). The MMLV vector, Constant, S., and Bottomly, K. (1997). Induction of TH1 and Th2
pGCIRES, will be described in detail elsewhere (G. L. C. and C. G. F., CD41 T cell responses: the alternative approaches. Annu. Rev. Im-
unpublished data). Both vectors express two cDNAs, T-bet and munol. 15, 297±322.
the cDNA encoding GFP, simultaneously using an IRES to initiate
Croft, M., Carter, L., Swain, S.L., and Dutton, R.W. (1994). Generationtranslation of each mRNA separately. Transfection of the packaging
of polarized antigen-specific CD8 effector populations: reciprocalcell line and retroviral transductions of primary T cells were per-
action of interleukin (IL)-4 and IL-12 in promoting type 2 versus typeformed as described (Ouyang et al., 1998).
1 cytokine profiles. J. Exp. Med. 180, 1715±1728.
Ferber, I.A., Lee, H.J., Zonin, F., Heath, V., Mui, A., Arai, N., andIntracellular Cytokine Staining and FACS Analysis
O'Garra, A. (1999). GATA-3 significantly downregulates IFN-g pro-Intracellular cytokine staining was performed as described (Ouyang
duction from developing Th1 cells in addition to inducing IL-4 andet al., 1998). Retrovirally transduced T cells were stimulated with
IL-5 levels. Clin. Immunol. 91, 134±144.PMA (50 ng/ml) and ionomycin (1 mM) for 4 hr with the addition of
3 mM monensin for the last 2 hr of stimulation. Cells were harvested, Fiorentino, D.F., Zlotnik, A., Vieira, P., Mosmann, T., Howard, M.,
washed twice in PBS, fixed in 4% paraformaldehyde for 10 min, Moore, D.W., and O'Garra, A. (1991). IL-10 acts on the antigen-
washed twice in PBS 1% FCS, resuspended in 0.1% saponin/1% presenting cell to inhibit cytokine production by Th1 cells. J. Immu-
FCS/PBS, and stained using either PE-conjugated anti-cytokine an- nol. 146, 3444±3451.
tibodies (Pharmingen) or control-Ig-PE for 30 min. Cells were Fisher, A.L., and Caudy, M. (1998). Groucho proteins: transcriptional
washed twice in 0.1% saponin/1% FCS/PBS, resuspended in PBS, corepressors for specific subsets of DNA-binding transcription fac-
and analyzed using a FACS Calibur. tors in vertebrates and invertebrates. Genes Dev. 12, 1931±1940.
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